EP2658399

ABBOTT LABORATORIES
Application Number
EP11809048A
Filing Date
Dec 22, 2011
Status
Patent Maintained As Amended
Jan 26, 2024
Grant Date
Feb 28, 2024
External Links
Slate, Register

Biblio Summary

The patent EP2658399B2 was granted on Feb 28, 2024 by Abbott Laboratories The patent is currently Patent Maintained As Amended.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

N.V. NUTRICIANov 27, 2019WITHDRAWN
SOCIETE DES PRODUITS NESTLE S.A.Nov 26, 2019DEEMED NOT TO HAVE BEEN FILED

The table below shows the patents of Abbott Laboratories that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3436822Decision Tree Based Systems And Methods For Estimating The Risk Of Acute Coronary SyndromeOct 18, 20231
EP3599898Liquid Nutritional Compositions Containing Oxidizable Fish Oil, Rosmarinic Acid And Ferric IronAug 17, 20221
EP3410874Whey Protein Based Liquid Nutritional CompositionMay 5, 20212

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.